Regeneron Pharmaceuticals, Inc.
(NASDAQ : REGN)

( )
REGN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.31%195.651.3%$518.42m
GILDGilead Sciences, Inc.
-0.27%65.780.9%$349.57m
ALXNAlexion Pharmaceuticals, Inc.
2.61%105.672.0%$327.78m
ILMNIllumina, Inc.
0.72%305.203.5%$315.92m
BIIBBiogen Inc.
0.19%235.621.3%$306.06m
CELGCelgene Corporation
0.28%98.951.3%$294.56m
AAgilent Technologies, Inc.
0.59%78.031.6%$175.77m
VRTXVertex Pharmaceuticals Incorporated
0.93%176.141.9%$174.75m
REGNRegeneron Pharmaceuticals, Inc.
0.38%286.152.6%$166.38m
SRPTSarepta Therapeutics, Inc.
2.02%85.3614.6%$145.24m
EXASExact Sciences Corporation
-1.94%103.4024.1%$138.75m
ACADACADIA Pharmaceuticals Inc.
-1.14%41.6813.9%$125.44m
INCYIncyte Corporation
-0.54%78.122.5%$85.20m
ALDRAlder Biopharmaceuticals, Inc.
-0.27%18.6610.2%$76.41m
BMRNBioMarin Pharmaceutical Inc.
0.66%76.004.3%$75.62m

Company Profile

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.